Clinical Trials Browser

Phase 3 × Recruiting × Mouth Neoplasms × Clear all

NCT06589804 2026-05-22

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

Phase 3 Recruiting

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms

NCT06798922 2026-03-03

OPTIFLAP

Phase 3 Recruiting

Mouth Neoplasms

NCT06737822 2025-03-04

SurVIC

Phase 3 Recruiting

Head and Neck Neoplasms, Mouth Neoplasms